Bg pattern

GLUCANTIME 1500 MG/5 ML INJECTABLE SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

5.0 (195)
Doctor

Taisiia Proida

Family medicine 7 years exp.

Taisiia Proida is a general practitioner with a specialization in mental health and a cognitive behavioral therapist (CBT), a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care. She specialises in consultations and ongoing support for a wide range of mental health concerns, including: 

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Assessment is provided only after an initial psychiatric evaluation and during a follow-up appointment.
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders. She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use GLUCANTIME 1500 MG/5 ML INJECTABLE SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet: information for the user

Glucantime 1,500 mg/5 ml injectable solution

Meglumine antimoniate

Read the entire leaflet carefully before starting to use this medicine, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any doubts, consult your doctor, pharmacist, or nurse.
  • This medicine has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

Contents of the leaflet:

  1. What Glucantime is and what it is used for
  2. What you need to know before taking Glucantime
  3. How to take Glucantime
  4. Possible side effects
  5. Storage of Glucantime
  6. Package contents and additional information
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

1. What Glucantime is and what it is used for

Glucantime belongs to a group of medicines called Leishmanicides.

Glucantime is indicated for the treatment of:

  • Visceral leishmaniasis (Kala azar)
  • Cutaneous leishmaniasis (Oriental button) and mucocutaneous leishmaniasis.

Leishmaniasis is a parasitic disease transmitted by the bite of a variety of mosquito.

2. What you need to know before taking Glucantime

Do not use Glucantime

  • if you are allergic to meglumine antimoniate or any of the other components of this medicine listed in section 6.
  • if you have kidney, heart, or liver failure (malfunction of the kidneys, heart, or liver).

Warnings and precautions

Consult your doctor or pharmacist before starting to use Glucantime.

  • If you are allergic, because Glucantime contains sulfites, which can induce or worsen important allergic reactions (anaphylactic-type).
  • If you experience an allergic reaction (see section "Possible side effects"). Contact your doctor or a healthcare professional or go to the emergency room of the nearest hospital immediately.
  • You will be asked to undergo liver and kidney function tests during treatment, due to the risk of intolerance to antimony, which is the component of Glucantime.

Stop using Glucantime and contact your doctor immediately if you experience any of the following symptoms:

  • nausea or vomiting, fever, feeling of tiredness, loss of appetite, dark-colored urine, light-colored stools, yellowish discoloration of the skin or the white part of the eyes, itching, rash, or pain in the upper abdomen.

These symptoms may be signs of liver problems.

  • Since meglumine antimoniate can cause cardiac disorders such as QT interval prolongation and severe arrhythmia, it is recommended to perform ECG controls during treatment. Your doctor should exercise caution when using this medicine if you have known risk factors for a cardiac disease called QT interval prolongation, such as:
  • you have an uncorrected electrolyte imbalance (e.g., low potassium or magnesium levels)
  • you have congenital long QT syndrome (inherited heart disease)
  • you have heart disease (e.g., myocardial infarction, decreased heart rate (bradycardia))
  • you are being treated with other medicines known to prolong the QT interval (e.g., Class IA and III antiarrhythmic drugs, some tricyclic antidepressants, some macrolide antibiotics, some antipsychotics, other antiparasitic drugs).
  • This medicine is not recommended for patients with L. aethiopicadue to the possibility of resistance.

  • In case of no response to this treatment, it is recommended to change it and use other leishmanicidal medicines.

Other medicines and Glucantime

Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine.

Medicines known to prolong the QT interval: meglumine antimoniate should be used with caution in patients being treated with medicines known to prolong the QT interval (e.g., Class IA and III antiarrhythmic drugs, some tricyclic antidepressants, some macrolides, some antipsychotics, other antiparasitic drugs) (see section "Warnings and precautions").

It is recommended to avoid simultaneous administration of Glucantime with medicines that have toxic effects on the heart, liver, pancreas, or nervous system.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Since the safety of Glucantime in pregnancy has not been demonstrated, it should not be administered during pregnancy, unless your doctor considers that the benefit of administering this medicine outweighs the possible risk to you and the fetus.

Animal studies have shown reproductive toxicity.

It is not known whether Glucantime is excreted in breast milk. For this reason, breastfeeding is not recommended during treatment with Glucantime.

Driving and using machines

No studies have been conducted on the ability to drive and use machines.

Glucantime contains sulfites, sodium, and potassium

This medicine can cause severe allergic reactions and bronchospasm (sudden feeling of suffocation) because it contains sulfites.

This medicine contains less than 23 mg of sodium (1 mmol) per 1 ml of injectable solution; it is essentially "sodium-free".

This medicine contains less than 39 mg (1 mmol) of potassium per 1 ml of injectable solution, so it is considered essentially "potassium-free".

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to take Glucantime

Follow your doctor's instructions for administering Glucantime exactly. If in doubt, consult your doctor again.

Glucantime is administered only by intramuscular injection.

Local pain may occur, so it is recommended to alternate the application area, preferably in the gluteal area.

The recommended dose is 20 mg/kg/day of antimony (75 mg/kg/day of meglumine antimoniate)

  • for 20 days in case of cutaneous leishmaniasis
  • for 28 days in case of visceral and mucocutaneous leishmaniasis.

Your doctor will indicate the duration of treatment.Do not stop treatment before.

If the disease persists or recurs after completing treatment, your doctor should refer you to a specialized service for follow-up. It may be necessary to repeat the treatment cycle in these cases.

Children:

Follow the same doses used for adults: 20 mg/kg/day of antimony (75 mg/kg/day of meglumine antimoniate).

  • 20 days in case of cutaneous leishmaniasis
  • 28 days in case of visceral and mucocutaneous leishmaniasis.

If you use more Glucantime than you should

If you receive more Glucantime than you should, consult your doctor or go to the nearest hospital immediately.

In case of overdose, gastrointestinal disorders (vomiting, diarrhea) of varying severity, skin disorders such as urticaria, liver disorders such as jaundice (yellowing of the skin), heart disorders (decreased heart rate, electrocardiogram changes), kidney disorders such as renal failure (malfunction of the kidneys), blood disorders, and nervous system disorders (nerve inflammation) may occur. In very rare cases, they can be life-threatening.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount used or ingested.

If you forget to use Glucantime

Do not take a double dose to make up for forgotten doses.

4. Possible side effects

Like all medicines, Glucantime can cause side effects, although not everyone gets them.

Side effects are classified according to their frequency, using the following convention:

Very common: may affect more than 1 in 10 people

Common: may affect up to 1 in 10 people

Uncommon: may affect up to 1 in 100 people

Rare: may affect up to 1 in 1,000 people

Very rare: may affect up to 1 in 10,000 people

Frequency not known: cannot be estimated from available data

The following side effects have been reported:

Immune system disorders

Frequency not known: allergic reactions (which can occur immediately or within several days after administration of the medicine), which can be life-threatening.

Symptoms may include skin rash, itching, difficulty breathing, shortness of breath, swelling of the face, lips, throat, or tongue, cold, clammy skin, palpitations, dizziness, weakness, or fainting.

Contact your doctor or healthcare professional or go to the emergency room of the nearest hospital immediately.

Metabolism and nutrition disorders

Common: loss of appetite (anorexia).

Nervous system disorders

Very common: headache.

Cardiac disorders

Common: changes in the electrocardiogram are dose-dependent and are generally reversible. In most cases, some changes in the electrocardiogram (inversion of the T wave and prolongation of the QT interval) precede the onset of severe arrhythmias.

Uncommon: severe arrhythmias (Torsade de Pointes, ventricular fibrillation), and in individual cases, they can be fatal.

Respiratory, thoracic, and mediastinal disorders

Uncommon: difficulty breathing (dyspnea).

Gastrointestinal disorders

Common: nausea and vomiting associated with antimony may occur at the start of treatment: abdominal pain.

Frequency not known: pancreatitis (inflammation of the pancreas).

Hepatobiliary disorders

Uncommon: abnormal liver enzyme levels (elevated liver enzymes: transaminases and alkaline phosphatase).

Frequency not known: an increase in liver enzyme levels is observed in laboratory tests, and sometimes, along with changes in kidney function tests (increased blood urea and serum creatinine).

Skin and subcutaneous tissue disorders

Uncommon: skin rash.

Musculoskeletal and connective tissue disorders

Very common: joint pain (arthralgia), muscle pain (myalgia).

Renal and urinary disorders

Frequency not known: changes in kidney function tests, kidney problems (acute renal failure).

General disorders and administration site conditions

Common: at the start of treatment, a transient febrile reaction may occur, accompanied by chills or a feeling of fainting with sweating, cough associated with antimony.

Uncommon: general malaise.

Frequency not known: facial swelling (facial edema); vein inflammation (thrombophlebitis) when not administered correctly.

It can also cause a decrease in white blood cell count (leukopenia) and anemia.

Reporting of side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Glucantime

Keep this medicine out of the sight and reach of children.

No special storage conditions are required.

Do not use Glucantime after the expiration date stated on the carton after EXP. The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicines in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.

6. Package contents and additional information

Composition of Glucantime

  • The active ingredient is meglumine antimoniate. Each ampoule contains 1,500 mg (equivalent to 405 mg of antimony).
  • The other ingredients are: potassium metabisulfite (E-224), sodium sulfite anhydrous (E-221), and water for injectable preparations.

Appearance of the product and package contents

Glucantime is a clear solution. In rare cases, small particles may be present in the solution. In this case, shake well before use. If the particles persist, do not use.

Glucantime is available in boxes of 10 ampoules of 5 ml.

Marketing authorization holder and manufacturer

Marketing authorization holder

sanofi-aventis, S.A.

C/ Roselló i Porcel, 21

08016 Barcelona

Spain

Manufacturer

Famar Health Care Services Madrid, S.A.U.

Avda. de Leganés, 62

28923 Alcorcón (Madrid)

Spain

Date of the last revision of this leaflet: October 2022

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/

Online doctors for GLUCANTIME 1500 MG/5 ML INJECTABLE SOLUTION

Discuss questions about GLUCANTIME 1500 MG/5 ML INJECTABLE SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Sviatoslav Chekhun

Oncology 13 years exp.

Dr. Sviatoslav Chekhun is a medical oncologist with international clinical and research experience, specializing in modern medical oncology and a personalized approach to cancer treatment.

Currently (since 2025), he works as a Medical Oncologist at Institut Català d’Oncologia (Girona, Spain). Previously, he completed his residency in Medical Oncology and was involved in clinical research at Hospital Universitari Germans Trias i Pujol.

Dr. Chekhun has a strong academic and scientific background. He served as a lecturer in Internal Medicine at O.O. Bohomolets National Medical University and conducted research in experimental oncology at the R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology.

Earlier in his career, he worked as a medical oncologist at the Kyiv City Clinical Oncological Center and contributed to regulatory evaluation of medicinal products at the State Expert Center of the Ministry of Health of Ukraine.

When to consult Dr. Chekhun:

  •  for diagnosis or clarification of a cancer diagnosis
  •  to obtain a second opinion on an existing treatment plan 
  •  when you need a personalized treatment strategy 
  •  for interpretation of test results, CT, MRI, PET-CT, and biopsies 
  •  when choosing between treatment options (chemotherapy, targeted therapy, immunotherapy) 
  •  in case of doubts about treatment strategy or disease progression 

Consultation format

Dr. Chekhun provides online consultations, where you can receive:

  •  expert second opinion 
  •  detailed case review 
  •  recommendations based on current international treatment guidelines 
  •  personalized treatment and follow-up plan 

Important:
Prescription and monitoring of medications must be carried out by your treating physician in an in-person (offline) setting. An online consultation does not replace a face-to-face visit but helps you make more informed decisions about your treatment.

Dr. Sviatoslav Chekhun combines clinical practice, research, and international experience, enabling him to provide patients with modern, evidence-based approaches in oncology.

5.0 (194)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

5.0 (43)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

5.0 (928)
Doctor

Alina Tsurkan

Family medicine 13 years exp.

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including:

  • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs.
  • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis.
  • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation.
  • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea.
  • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections.
  • Chronic diseases: hypertension, elevated cholesterol, weight management.
  • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness.
  • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance.

She also provides:

  • IMT medical certificates for driving licence exchange in Portugal.
  • Personalised preventive care and wellness consultations.
  • Interpretation of test results and medical reports.
  • Follow-up care and medication review.
  • Support in managing multiple coexisting conditions.
  • Remote prescription management and medical documentation.

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

5.0 (195)
Doctor

Taisiia Proida

Family medicine 7 years exp.

Taisiia Proida is a general practitioner with a specialization in mental health and a cognitive behavioral therapist (CBT), a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care. She specialises in consultations and ongoing support for a wide range of mental health concerns, including: 

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Assessment is provided only after an initial psychiatric evaluation and during a follow-up appointment.
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders. She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

5.0 (2)
Doctor

Alexander Nazarchuk

Allergology 7 years exp.

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

  • Test interpretation and guidance on diagnostic plans.
  • Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
  • Food and drug allergies, skin rashes, angioedema.
  • Atopic dermatitis, urticaria, contact allergies.
  • Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
  • Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
  • High blood pressure and adjustment of baseline antihypertensive therapy.
  • Hyperlipidaemia and elevated cholesterol.
  • Cough, nasal congestion, fever, sore throat.
  • Anaemia, including iron deficiency and related conditions.
  • Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.

Camera Book a video appointment
€55
5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80

Get GLUCANTIME 1500 MG/5 ML INJECTABLE SOLUTION Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for GLUCANTIME 1500 MG/5 ML INJECTABLE SOLUTION?

GLUCANTIME 1500 MG/5 ML INJECTABLE SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in GLUCANTIME 1500 MG/5 ML INJECTABLE SOLUTION?

The active ingredient in GLUCANTIME 1500 MG/5 ML INJECTABLE SOLUTION is meglumine antimonate. This information helps identify medicines with the same composition but different brand names.

Who manufactures GLUCANTIME 1500 MG/5 ML INJECTABLE SOLUTION?

GLUCANTIME 1500 MG/5 ML INJECTABLE SOLUTION is manufactured by Sanofi Aventis S.A.. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of GLUCANTIME 1500 MG/5 ML INJECTABLE SOLUTION online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether GLUCANTIME 1500 MG/5 ML INJECTABLE SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy GLUCANTIME 1500 MG/5 ML INJECTABLE SOLUTION in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy GLUCANTIME 1500 MG/5 ML INJECTABLE SOLUTION in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to GLUCANTIME 1500 MG/5 ML INJECTABLE SOLUTION?

Other medicines with the same active substance (meglumine antimonate) include LAMPIT 120 mg TABLETS, LAMPIT 30 mg TABLETS, PENTACARINAT 300 mg POWDER FOR INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media